FBInvestor
Stocks / Abiomed Inc
Institutional Ownership

Abiomed Inc

CUSIP 003654100COMABMDEURQ1 2026

13D / 13G Filings
18
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
10.6%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

18 filings · latest Jan 6, 2023

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Jan 6, 2023Baillie Gifford & Co13G/A0.0%3.0KSEC
2Dec 29, 2022Millennium Management LLC13GSEC
3Feb 9, 2022Vanguard Group Inc13G/A10.6%4.84MSEC
4Feb 4, 2022Wellington Management Group LLP13G5.4%2.46MSEC
5Jan 18, 2022Baillie Gifford & Co13G/A8.4%3.84MSEC
6Jan 10, 2022Blackrock Inc.13G/A10.1%4.59MSEC
7Feb 16, 2021Sands Capital Management, LLC13G3.3%1.48MSEC
8Feb 10, 2021Vanguard Group Inc13G/A10.6%4.80MSEC
9Feb 10, 2021Renaissance Technologies LLC13G/A4.4%1.99MSEC
10Jan 29, 2021Blackrock Inc.13G/A9.1%4.13MSEC

8 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Abiomed Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →
#FundSharesValue
1Huntington National Bank1$381